×
About 1,880 results

ALLMedicine™ Hepatorenal Syndrome Center

Research & Reviews  895 results

Development and validation of a prognostic model for patients with hepatorenal syndrome...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160623
World Journal of Gastroenterology; Sheng XY, Lin FY et. al.

Jun 7th, 2021 - Hepatorenal syndrome (HRS) is a severe complication of cirrhosis with high mortality, which necessitates accurate clinical decision. However, studies on prognostic factors and scoring systems to predict overall survival of HRS are not enough. Mean...

Midodrine and albumin versus albumin alone for the secondary prophylaxis of acute kidne...
https://doi.org/10.1097/MEG.0000000000002154
European Journal of Gastroenterology & Hepatology; Sharma P, Puri P et. al.

May 25th, 2021 - Acute kidney injury (AKI) in a patient with cirrhosis has high short-term mortality. Midodrine has shown promising results in the treatment of AKI-hepatorenal syndrome (HRS-AKI). To compare midodrine and albumin versus albumin alone for the second...

Towards norepinephrine as first line treatment for all hospitalized patients with HRS.
https://doi.org/10.1002/lt.26106
Liver Transplantation : Official Publication of the Ameri... Paine C, Pichler R et. al.

May 24th, 2021 - Hepatorenal syndrome (HRS) is a devastating complication of advanced liver disease associated with high mortality. Despite having been described as a clinical syndrome more than 60 years ago, options for the treatment of HRS remain very limited. M...

Pituitary apoplexy and panhypopituitarism following acute leptospirosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139373
Pituitary Gohil J, Gowda A et. al.

May 22nd, 2021 - Leptospirosis is a common tropical febrile illness which may manifest with the hepatorenal syndrome and systemic hemorrhagic manifestations. Pituitary apoplexy is a rare but life-threatening condition characterized by a hemorrhage within the pitui...

Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116001
Clinical and Translational Gastroenterology; Allegretti AS, Parada XV et. al.

May 12th, 2021 - Urinary neutrophil gelatinase-associated lipocalin (NGAL) has shown promise in differentiating acute tubular necrosis (ATN) from other types of acute kidney injuries (AKIs) in cirrhosis, particularly hepatorenal syndrome (HRS). However, NGAL is no...

see more →

Guidelines  1 results

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial p...
https://doi.org/10.1016/j.jhep.2010.05.004
Journal of Hepatology;

Jul 16th, 2010 - EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.|2010| ,|therapeutic use,diagnosis,etiology,therapy,diagnosis,etiology,therapy,therapeutic use,diagnosis,etiol...

see more →

Clinicaltrials.gov  931 results

Development and validation of a prognostic model for patients with hepatorenal syndrome...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160623
World Journal of Gastroenterology; Sheng XY, Lin FY et. al.

Jun 7th, 2021 - Hepatorenal syndrome (HRS) is a severe complication of cirrhosis with high mortality, which necessitates accurate clinical decision. However, studies on prognostic factors and scoring systems to predict overall survival of HRS are not enough. Mean...

Midodrine and albumin versus albumin alone for the secondary prophylaxis of acute kidne...
https://doi.org/10.1097/MEG.0000000000002154
European Journal of Gastroenterology & Hepatology; Sharma P, Puri P et. al.

May 25th, 2021 - Acute kidney injury (AKI) in a patient with cirrhosis has high short-term mortality. Midodrine has shown promising results in the treatment of AKI-hepatorenal syndrome (HRS-AKI). To compare midodrine and albumin versus albumin alone for the second...

Towards norepinephrine as first line treatment for all hospitalized patients with HRS.
https://doi.org/10.1002/lt.26106
Liver Transplantation : Official Publication of the Ameri... Paine C, Pichler R et. al.

May 24th, 2021 - Hepatorenal syndrome (HRS) is a devastating complication of advanced liver disease associated with high mortality. Despite having been described as a clinical syndrome more than 60 years ago, options for the treatment of HRS remain very limited. M...

Pituitary apoplexy and panhypopituitarism following acute leptospirosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139373
Pituitary Gohil J, Gowda A et. al.

May 22nd, 2021 - Leptospirosis is a common tropical febrile illness which may manifest with the hepatorenal syndrome and systemic hemorrhagic manifestations. Pituitary apoplexy is a rare but life-threatening condition characterized by a hemorrhage within the pitui...

Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116001
Clinical and Translational Gastroenterology; Allegretti AS, Parada XV et. al.

May 12th, 2021 - Urinary neutrophil gelatinase-associated lipocalin (NGAL) has shown promise in differentiating acute tubular necrosis (ATN) from other types of acute kidney injuries (AKIs) in cirrhosis, particularly hepatorenal syndrome (HRS). However, NGAL is no...

see more →

News  53 results

Terlipressin Shows Benefit in Hepatorenal Syndrome but Risks Spark Concern
https://www.medscape.com/viewarticle/946833

Mar 3rd, 2021 - NEW YORK (Reuters Health) - Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome (HRS-1), although not without potentially serious side effects. The study, published i...

Terlipressin Squeaks by FDA Review for Hepatorenal Syndrome 1
https://www.staging.medscape.com/viewarticle/934042

Jul 15th, 2020 - The US Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval to terlipressin for the treatment of hepatorenal syndrome type 1, a seve...

Terlipressin Squeaks by FDA Review for Hepatorenal Syndrome 1
https://www.medscape.com/viewarticle/934042

Jul 15th, 2020 - The US Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval to terlipressin for the treatment of hepatorenal syndrome type 1, a seve...

Alcoholism and Sudden Abdominal Distention in a 48-Year-Old
https://reference.medscape.com/viewarticle/724935_5

Jul 5th, 2020 - In this case, the patient's postprocedural course was characterized initially by worsening liver failure, elevated intra-abdominal pressures, and confusion. He eventually progressed to frank encephalopathy, hepatorenal syndrome, and pneumonia. Ult...

Terlipressin Shows Real-world Efficacy for Hepatorenal Syndrome
https://www.staging.medscape.com/viewarticle/932202

Jun 11th, 2020 - Takeaway Terlipressin is the most commonly prescribed vasoconstrictor for hospitalised patients with hepatorenal syndrome-acute kidney injury (HRS-AKI) in the UK, consistent with current guidelines. Initiation of terlipressin in patients with less...

see more →